Identification of colorectal cancer recurrence-related microRNAs

Jian-an Ju , Yuan-ching Huang , Sheng-hui Lan , Ting-huei Wang , Peng-chan Lin , Jheng-chang Lee , Ko-chi Niu , Yu-feng Tian , Hsiao-sheng Liu
{"title":"Identification of colorectal cancer recurrence-related microRNAs","authors":"Jian-an Ju ,&nbsp;Yuan-ching Huang ,&nbsp;Sheng-hui Lan ,&nbsp;Ting-huei Wang ,&nbsp;Peng-chan Lin ,&nbsp;Jheng-chang Lee ,&nbsp;Ko-chi Niu ,&nbsp;Yu-feng Tian ,&nbsp;Hsiao-sheng Liu","doi":"10.1016/j.gmbhs.2012.04.005","DOIUrl":null,"url":null,"abstract":"<div><p>Colorectal cancer (CRC) has high recurrence rate.Effective biomarkers for the detection of colon cancer are still unavailable. MicroRNA (miRNA) is an epigenetic factor that regulates cell proliferation, tumor cell growth, cancer formation, and metastasis by regulating tumor suppressor genes or oncogenes. miRNA has the potential to be used as a biomarker for the diagnosis of diverse cancers. Previously, we revealed that miR-139-3 p is downregulated and miR-338-5 p is upregulated in recurrent CRC patients. The present study further reveals that the miR-139-3 p expression level is inversely correlated with increased metastatic status in three colon cancer cell lines (SW480, SW620, and colo201), as determined using real-time polymerase chain reaction. Furthermore, in 51 pairs of CRC clinical specimens, the expression level of mir-139-3 p was significantly lower in the tumor sections than in the adjacent normal tissues (<em>p</em> &lt; 0.0001), indicating that they are tumor-suppressive miRNAs. Furthermore, the expression level of mir-338-5 p in the tumor tissues of metastatic patients was significantly higher than in the tumor tissues of nonmetastatic patients (<em>p</em> &lt; 0.05), indicating that mir-338-5 p is positively correlated with metastasis. All together, mir-139-3 p and mir-338-5 p may have potential use as biomarkers for the diagnosis of tumor formation and metastasis in CRC patients.</p></div>","PeriodicalId":100577,"journal":{"name":"Genomic Medicine, Biomarkers, and Health Sciences","volume":"4 1","pages":"Pages 19-20"},"PeriodicalIF":0.0000,"publicationDate":"2012-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.gmbhs.2012.04.005","citationCount":"8","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Genomic Medicine, Biomarkers, and Health Sciences","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2211425412000131","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 8

Abstract

Colorectal cancer (CRC) has high recurrence rate.Effective biomarkers for the detection of colon cancer are still unavailable. MicroRNA (miRNA) is an epigenetic factor that regulates cell proliferation, tumor cell growth, cancer formation, and metastasis by regulating tumor suppressor genes or oncogenes. miRNA has the potential to be used as a biomarker for the diagnosis of diverse cancers. Previously, we revealed that miR-139-3 p is downregulated and miR-338-5 p is upregulated in recurrent CRC patients. The present study further reveals that the miR-139-3 p expression level is inversely correlated with increased metastatic status in three colon cancer cell lines (SW480, SW620, and colo201), as determined using real-time polymerase chain reaction. Furthermore, in 51 pairs of CRC clinical specimens, the expression level of mir-139-3 p was significantly lower in the tumor sections than in the adjacent normal tissues (p < 0.0001), indicating that they are tumor-suppressive miRNAs. Furthermore, the expression level of mir-338-5 p in the tumor tissues of metastatic patients was significantly higher than in the tumor tissues of nonmetastatic patients (p < 0.05), indicating that mir-338-5 p is positively correlated with metastasis. All together, mir-139-3 p and mir-338-5 p may have potential use as biomarkers for the diagnosis of tumor formation and metastasis in CRC patients.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
结直肠癌复发相关microrna的鉴定
结直肠癌(CRC)复发率高。目前还没有检测结肠癌的有效生物标志物。MicroRNA (miRNA)是一种通过调节抑癌基因或致癌基因,调控细胞增殖、肿瘤细胞生长、肿瘤形成和转移的表观遗传因子。miRNA有可能被用作多种癌症诊断的生物标志物。之前,我们发现在复发性CRC患者中mir -139- 3p下调,mir -338- 5p上调。本研究进一步揭示,mir -139- 3p表达水平与三种结肠癌细胞系(SW480、SW620和col201)转移状态的增加呈负相关,这是通过实时聚合酶链反应确定的。此外,在51对结直肠癌临床标本中,mir-139- 3p在肿瘤切片中的表达水平明显低于邻近正常组织(p <0.0001),表明它们是肿瘤抑制mirna。此外,mir-338- 5p在转移患者肿瘤组织中的表达水平显著高于非转移患者的肿瘤组织(p <0.05),表明mir-338- 5p与转移呈正相关。总之,mir-139- 3p和mir-338- 5p可能具有作为CRC患者肿瘤形成和转移诊断的生物标志物的潜在用途。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Development of beverage product from Gynura bicolor and evaluation of its antioxidant activity Changes in levels of copper, iron, zinc, and selenium in patients at different stages of chronic kidney disease Antihyperglycemic and antioxidative effect of hydro - methanolic (2:3) extract of the seed of Swietenia mahagoni (L.) Jacq. in streptozotocin-induced diabetic male albino rat: An approach through pancreas Urinary tract infection among neonates in Benin City, Nigeria An observational study of bevacizumab combined with FOLFIRI as the first-line treatment in metastatic colorectal cancer
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1